throwing us a party at CYN soon. Everyone's invited. idk bout hamburgers but we'll be doing some grillin! 
, your list helps a lot to narrow things down and do my own research, you are doing great work day after day!![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Argo Blockchain
ARBK
BTCS Inc
BTCS
Canaan
CAN
Bit Origin
BTOG
Bitfarms
BITF
US Stock MarketDetailed Quotes
SLS Sellas Life Sciences
- 1.320
- +0.050+3.94%
Close Feb 14 16:00 ET
- 1.320
- -0.001-0.04%
Post 19:56 ET
103.73MMarket Cap-1.97P/E (TTM)
1.320High1.240Low1.34MVolume1.290Open1.270Pre Close1.72MTurnover1.71%Turnover RatioLossP/E (Static)78.58MShares1.84052wk High6.53P/B103.35MFloat Cap0.73052wk Low--Dividend TTM78.30MShs Float554.500Historical High--Div YieldTTM6.30%Amplitude0.499Historical Low1.284Avg Price1Lot Size
Sellas Life Sciences Stock Forum
Sign in to post a comment
$Sellas Life Sciences (SLS.US)$
SELLAS Life Sciences Group Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Tuesday, 28th January at 3:11 pm
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS" or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that it has entered into a securities purchas...
SELLAS Life Sciences Group Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Tuesday, 28th January at 3:11 pm
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS" or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that it has entered into a securities purchas...
2
3
NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after ...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after ...
78
18
6
$Sellas Life Sciences (SLS.US)$
The interim analysis of SELLAS' Phase 3 REGAL trial represents a pivotal moment in AML treatment development. The trial's continuation recommendation by the IDMC is particularly significant for several reasons:
The survival data is remarkably promising - with fewer than 50% of patients deceased at 13.5 months median follow-up, mor...
The interim analysis of SELLAS' Phase 3 REGAL trial represents a pivotal moment in AML treatment development. The trial's continuation recommendation by the IDMC is particularly significant for several reasons:
The survival data is remarkably promising - with fewer than 50% of patients deceased at 13.5 months median follow-up, mor...
NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
8. With regards to ...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
8. With regards to ...
49
15
7
$Sellas Life Sciences (SLS.US)$ Reuters· just
Sellas Life Sciences Group Inc: 80% Of Randomly Selected Regal Gps Patients Showed a Specific T-Cell Immune Response! Trial to continue without modification
Sellas Life Sciences Group Inc: 80% Of Randomly Selected Regal Gps Patients Showed a Specific T-Cell Immune Response! Trial to continue without modification
1
14
$Sellas Life Sciences (SLS.US)$
SELLAS Life Sciences Announces Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia
Thursday, 23rd January at 8:10 am
- REGAL Successfully Passes Event-Driven (60 Deaths) Interim Analysis for Efficacy, Futility, and Safety: The Independent Data Monitoring Committee (IDMC) Recommended Continuation of the Clinical Trial Without Modification –
- Based on a Review of Unblinded Data, the IDMC Confirmed that GPS Ex...
SELLAS Life Sciences Announces Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia
Thursday, 23rd January at 8:10 am
- REGAL Successfully Passes Event-Driven (60 Deaths) Interim Analysis for Efficacy, Futility, and Safety: The Independent Data Monitoring Committee (IDMC) Recommended Continuation of the Clinical Trial Without Modification –
- Based on a Review of Unblinded Data, the IDMC Confirmed that GPS Ex...
1
$Sellas Life Sciences (SLS.US)$ SELLAS Life Sciences Group (NASDAQ: SLS) outlined key business objectives for 2025, highlighting two major upcoming milestones. The company expects an interim analysis of its Phase 3 REGAL study by an Independent Data Monitoring Committee in January 2025, which will determine whether to stop the trial early for efficacy, stop for futility, or continue without modification.
Additionally, full topline Phase 2 data for SLS009 (tambiciclib) in Acute Myeloid Leu...
Additionally, full topline Phase 2 data for SLS009 (tambiciclib) in Acute Myeloid Leu...
1
$Sellas Life Sciences (SLS.US)$
SELLAS Life Sciences Triggers Interim Analysis in Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia
Tuesday, 10th December at 8:30 am
- Study Reaches Pre-Specified Threshold of 60 Events (Deaths) Initiating the Interim Analysis –
- REGAL Independent Data Monitoring Committee to Perform Interim Analysis in January 2025 -
- Company to Host Webcast Call Today at 9:00 am ET
NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: ...
SELLAS Life Sciences Triggers Interim Analysis in Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia
Tuesday, 10th December at 8:30 am
- Study Reaches Pre-Specified Threshold of 60 Events (Deaths) Initiating the Interim Analysis –
- REGAL Independent Data Monitoring Committee to Perform Interim Analysis in January 2025 -
- Company to Host Webcast Call Today at 9:00 am ET
NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: ...
No comment yet
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
104806367 : The issue price is 1.20, does this mean its value is 1.2 higher?
Jaguar8 OP 104806367 : Not necessarily. Price of warrants can be exercised lower in certain conditions like stock price is way lower, immediate need of capital etc. They can exercised the warrant anytime and at a higher price. In terms of exercising warrants, it can dilute because exercising creates new shares
104806367 Jaguar8 OP : Thank you for sharing.